Joel Palefsky is an internationally recognized expert on the molecular biology, treatment, pathogenesis and natural history of anogenital human papillomavirus infections, particularly in the setting of HIV infection. He is the Director of the world's first clinic devoted to prevention of anal cancer, the Anal Neoplasia Clinic at the UCSF Cancer Center. He has pioneered diagnostic and treatment methods for anal intraepithelial neoplasia (AIN) and has been an advocate for screening and treatment of AIN in high-risk populations to prevent anal cancer. He is the chair of the HPV Working Group of the U.S. National Cancer Institute-supported AIDS Malignancy Consortium. He founded and leads the HIV-related Malignancies Research Group at UCSF. He is the founder and immediate past president of the International Anal Neoplasia Society and is the current president of the International Papillomavirus Society. He is principal investigator of the ANal Cancer/HSIL Outcomes Research (ANCHOR) study and is the author of over 280 publications.
At the completion of this educational session, learners will:
- Understand the current epidemiology of anal cancer, pre-cancer and HPV infection in HIV-positive individuals.
- Be aware of current methods for prevention of anal cancer in HIV-positive individuals.
- Know the design and rational for, and current status of, the Anal Cancer/HSIL Outcomes Research (ANCHOR) study.
This CME activity was approved for AMA PRA Category 1 Credit™
on February 9, 2016 and will terminate February 8, 2019.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Palefsky (Presenter) had the following personal financial relationships in the prior 12 months with manufacturers of the products and/or services that may be presented in this CME activity: Grants/Research Support Recipient from Merck, Hologic, Vax, and Cel-Sci; advisor to Vax, and Agenovir; board member at Merck; review panel member at Vax; stock shareholder of Ubiome; travel reimbursements from Merck, and Hologic. Dr. Palefsky submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the PRN Video Channel
at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.